Recurrent Miscarriage Treatment in Delhi

Recurrent miscarriage is the loss of two or more pregnancies before 20 weeks. It affects roughly 1 in 100 couples worldwide, with Indian women showing a prevalence of 7.46% in published research, higher than western figures. In most cases, a diagnosable cause exists: chromosomal issues, uterine problems, hormonal imbalances, or blood clotting disorders. At Mediworld Fertility in Delhi, over 1,500 couples have received structured evaluation and treatment for recurrent pregnancy loss, with evidence-based care at every step.

What Is Recurrent Miscarriage and When Should You Seek Help?

Recurrent miscarriage is the loss of two or more consecutive pregnancies before 20 weeks of gestation. The American Society of Reproductive Medicine updated its definition in recent years from three losses to two, recognising that waiting for a third loss before investigation causes unnecessary harm. Most specialists now recommend a full evaluation after two consecutive losses.

That definition matters because it changes when couples should act. Two losses in a row is not bad luck to push through. It’s a signal that something may need investigating.

There are two clinical subtypes worth knowing:

• Primary recurrent pregnancy loss is when a couple has never had a successful pregnancy.
• Secondary recurrent pregnancy loss is when losses follow at least one healthy pregnancy. The prognosis for secondary RPL tends to be better, but both need proper evaluation.

The emotional toll of repeated loss often gets underestimated. Anxiety about another pregnancy is normal and expected. That’s one reason we pair clinical care with dedicated counselling at every stage.

What Are the Most Common Causes of Recurrent Miscarriage?

Recurrent miscarriage has five main cause categories: chromosomal or genetic abnormalities (responsible for roughly half of all pregnancy losses), uterine structural problems, hormonal and endocrine disorders, immunological conditions like antiphospholipid syndrome, and blood clotting disorders. In around 50% of cases, a cause can be identified and addressed. The remaining cases are classified as unexplained, though supportive care still significantly improves outcomes.

Here’s how each cause category works:

• Chromosomal and genetic factors. Around half of all early pregnancy losses involve chromosomal abnormalities in the embryo, according to the MSD Manual (reviewed February 2024). These can be random errors in cell division or the result of a balanced chromosomal rearrangement in one or both parents. Parental chromosomal rearrangements are found in 2-5% of couples with recurrent pregnancy loss.
• Uterine structural problems. A uterine septum (a wall of tissue inside the uterus that shouldn’t be there), fibroids, polyps, or scar tissue from previous procedures can all prevent a pregnancy from implanting or developing properly. These are often treatable with surgery.
• Hormonal and endocrine disorders. Thyroid dysfunction, especially hypothyroidism, is one of the most common and most treatable causes. Uncontrolled diabetes, elevated prolactin levels, and luteal phase defects also fall into this category.
• Antiphospholipid syndrome (APS). This is the most important treatable immunological cause of recurrent miscarriage. APS is present in roughly 15% of women with recurrent pregnancy loss, according to RCOG guidelines. It causes the immune system to produce antibodies that interfere with normal clotting and placental function.
• Blood clotting disorders. Beyond APS, other inherited thrombophilias can reduce blood flow to the developing baby, increasing the risk of loss.
• Male factor contribution. Research shows that sperm quality and chromosomal abnormalities in the male partner can also contribute to recurrent pregnancy loss. This is why semen analysis is part of any complete evaluation.
• Infections. Conditions like TORCH infections (toxoplasma, rubella, cytomegalovirus, herpes) have shown a significant association with recurrent spontaneous miscarriage in Indian studies.
• Unexplained RPL. When all tests come back normal, the cause is classified as unexplained. This accounts for roughly half of all cases. Supportive care and close monitoring in early pregnancy have been shown to significantly improve outcomes even in this group.

Recurrent Miscarriage Risk Factors: Who Is Most at Risk?

Age is the single most consistent risk factor for Recurrent Miscarriages. The risk rises further with each passing year, particularly above 40, because egg quality and chromosomal integrity decline with age.

A history of previous miscarriages also increases the risk. After three losses, the chance of another miscarriage sits at roughly 30%. That still means 70% of couples in that situation go on to carry a healthy pregnancy, especially with the right care.

Other significant risk factors include:

• Thyroid disorders and PCOS. An Indian expert consensus published in June 2024 identified thyroid disease and polycystic ovarian disease as the major contributors to recurrent pregnancy loss among Indian women. Both are very treatable once identified.
• Lifestyle factors. Data from India’s NFHS-5 national health survey, published in the Journal of Family Medicine and Primary Care in September 2024, found that obesity, hypertension, severe anaemia, and tobacco use were all significant risk factors for miscarriage in Indian women. Managing these conditions before and during pregnancy reduces risk meaningfully.
• Antiphospholipid antibodies. As noted above, these are found in 15% of women with recurrent pregnancy loss. Testing for them is a standard part of any recurrent miscarriage workup.
• Uterine anomalies. A uterine septum, the most common uterine malformation, often goes undetected until investigations begin.

If you have PCOD and fertility concerns, getting this evaluated before your next pregnancy attempt is especially important.

How Is Recurrent Miscarriage Diagnosed? Tests and Medical Evaluation

Diagnosis starts with your full reproductive history: how many losses, at what stage, whether any tissue was tested, and what prior investigations have shown. That context shapes which tests matter most. The workup then covers four areas: genetic, hormonal, immunological, and uterine. No single test tells the full story, and gaps in the workup often mean missed diagnoses.

The standard evaluation at Mediworld Fertility includes:

• Genetic testing. Karyotyping of both partners checks for chromosomal rearrangements that could be contributing to losses. This is particularly important when multiple unexplained losses have occurred.
• Uterine evaluation. A transvaginal ultrasound gives an initial picture of the uterine cavity. Hysteroscopy in Delhi gives a direct internal view and can diagnose a uterine septum, polyps, fibroids, or scar tissue with precision. Hysterosalpingography (HSG) may also be used to assess the uterine cavity and tubes.
• Hormonal panel. This covers thyroid function (TSH and antibodies), prolactin, progesterone, fasting blood glucose, and ovarian reserve markers. Hormonal imbalances often fly under the radar and are missed without a targeted test panel.
• Immunological testing. Antiphospholipid antibody testing, lupus anticoagulant, and anticardiolipin antibodies identify the presence of APS. A positive result on two separate occasions, at least 12 weeks apart, is needed for diagnosis.
• Semen analysis. Male factor evaluation is part of the standard workup. Sperm DNA fragmentation testing may be recommended for couples with otherwise unexplained losses.
• Infection screening. TORCH profile testing identifies infections that may be affecting early pregnancy.
• Diabetes screening. Uncontrolled blood sugar is a known and treatable contributor to recurrent loss.

Our advanced diagnostic infrastructure at Mediworld Fertility means all these investigations are available under one roof, with results interpreted by fertility specialists who understand how each finding connects to your specific history.

Recurrent Miscarriage Treatment in Delhi: What Are Your Options?

Treatment for recurrent miscarriage is determined entirely by the cause found during evaluation. There is no universal protocol. The right treatment for chromosomal RPL is different from the right treatment for APS, which is different again from the right treatment for a uterine septum. That’s why the diagnosis comes first.

Here’s what treatment looks like across the main cause categories:

• For antiphospholipid syndrome (APS). The combination of low-dose aspirin and heparin is the established first-line treatment. A landmark clinical trial funded by Arthritis UK found that women with recurrent miscarriage and APS who received aspirin plus heparin had a 71% live birth rate, compared to 42% with aspirin alone. A 2020 network meta-analysis published in Lupus, covering 54 randomised controlled trials, confirmed low-dose aspirin plus heparin as the recommended first-line approach for APS-related recurrent pregnancy loss.
• For uterine structural problems. A uterine septum is treated with hysteroscopic resection, a minimally invasive surgical procedure. Data from Fertility and Sterility found that in a recurrent pregnancy loss group with uterine septum, the live birth rate rose from 2.4% before surgery to 75% after hysteroscopic septum incision. The 2024 ASRM uterine septum guideline recommends offering hysteroscopic septum incision to patients with a septum and a history of recurrent miscarriage, on a shared decision-making basis. Fibroids and polyps that affect the uterine cavity are also removed hysteroscopically.
• For chromosomal and genetic causes. IVF treatment in Delhi combined with preimplantation genetic testing for aneuploidy (PGT-A) allows doctors to screen embryos before transfer, selecting only those with the correct number of chromosomes. This is covered in detail in the next section.
• For hormonal causes. Thyroid disorders are treated with levothyroxine to bring TSH levels into the optimal range before conception. Elevated prolactin is managed with medication. Progesterone support in early pregnancy may be recommended for luteal phase defects.
• For unexplained recurrent pregnancy loss. Supportive care in early pregnancy, close monitoring through an early pregnancy clinic, and lifestyle modification (weight, diet, stress management, stopping smoking) have all shown meaningful benefits. Emotional support and counselling are part of the plan.

Each treatment plan at Mediworld Fertility is built around what the investigation actually shows, not a one-size approach. For couples managing high-risk pregnancy care alongside RPL, our multidisciplinary team manages both together.

How Does IVF with Genetic Testing Help in Recurrent Pregnancy Loss?

For couples where chromosomal abnormalities in embryos are the reason behind repeated losses, IVF combined with preimplantation genetic testing for aneuploidy (PGT-A) allows selection of only chromosomally normal embryos for transfer. By removing aneuploid embryos from the transfer pool, the risk of a chromosomally caused miscarriage is significantly reduced. National data from the Society for Assisted Reproductive Technology (SART) found that PGT-A is associated with higher implantation rates and lower miscarriage rates, particularly in older age groups.

• PGT-A works like this: after eggs are retrieved and fertilised through ICSI treatment or standard IVF, the resulting embryos develop to the blastocyst stage over five to six days. A small number of cells are taken from each embryo and tested using next-generation sequencing. Only embryos with the correct 46 chromosomes are selected for transfer.
• The 2024 ASRM committee opinion on PGT-A confirms that analysis of SART data shows PGT-A is associated with higher implantation rates and lower miscarriage rates, with the benefit most pronounced in women of advanced maternal age.

Who benefits most from IVF with PGT-A in the context of recurrent pregnancy loss? Women over 37, couples with a known parental chromosomal rearrangement, and those with a history of proven aneuploid losses are the clearest candidates. For younger women with unexplained RPL and normal karyotypes, the picture is more nuanced and should be discussed with a specialist based on individual circumstances.

At Mediworld Fertility, we have completed over 2,000 IVF and ICSI cycles. Our embryology team, led by Dr. Sushma Ved with 22+ years of experience and 6,000+ procedures performed, handles PGT-A cycles with the precision these cases demand. A consultation with our IVF treatment specialists in Delhi will clarify whether this path makes sense for your specific situation.

Can You Have a Healthy Pregnancy After Recurrent Miscarriage?

Yes. And the data here is genuinely reassuring, because many couples arrive at the clinic believing their situation is hopeless.

Even after three consecutive miscarriages with no treatment, the chance of carrying a successful pregnancy in the next attempt is roughly 70%. That figure comes from the same Indian epidemiology study that documented the 30% risk of a subsequent miscarriage after three losses. It means the majority of couples in this situation do go on to have a healthy pregnancy, even without intervention.

With proper diagnosis and targeted treatment, outcomes improve substantially. Couples treated for APS see live birth rates of 71% or higher. Those with a uterine septum who undergo hysteroscopic resection see live birth rates around 75%. Couples using IVF with PGT-A who have a history of chromosomal losses see significantly reduced miscarriage rates per transfer.

At Mediworld Fertility, we have managed over 1,500 recurrent pregnancy loss cases and have conducted over 2,000 couple counselling sessions. Our success rate in advanced IVF and fertility treatments is 95%. We don’t share those numbers to impress. We share them because couples going through this deserve to know that successful outcomes are achievable, with the right support.

Specialists Treating Recurrent Miscarriage at Mediworld Fertility

Recurrent pregnancy loss is one of the more complex areas of reproductive medicine. It sits at the intersection of genetics, immunology, hormonal medicine, and surgery. Getting the right team matters.

• Dr. Neha Gupta is the Clinical Director and Senior IVF Specialist at Mediworld Fertility, with 21 years of experience in reproductive medicine. She has treated over 2,000 couples across IVF, ICSI, recurrent implantation failure, and recurrent pregnancy loss. She leads the RPL evaluation and treatment protocols at our centres and is known for taking the time to explain each finding and each option clearly,You can read more about her approach on the Dr. Neha Gupta profile page.
• Dr. Sushma Ved is Director and Senior Consultant in Embryology, with 22 years of experience and over 6,000 procedures performed. She oversees our IVF laboratory, embryo quality assessment, and PGT-A cycles, all of which are central to treatment when chromosomal causes are identified.
• Our supporting team of consultants, Dr. Deepti Pachauri, Dr. Manisha Bansal, and Dr. Reeta Agrawal, are each experienced gynaecologists and obstetricians managing cases across our Delhi NCR satellite centres in Faridabad, Ghaziabad, and Greater Noida.

The team works as a unit. When a recurrent miscarriage case comes in, the fertility specialist, embryologist, counsellor, and nursing team are all part of the picture. That’s not a marketing claim. It’s the practical reality of how complex cases get managed well.

For patients from outside Delhi, our international patient support team handles appointments, investigations, and communication remotely.

Why Choose Mediworld Fertility for Recurrent Miscarriage Treatment in Delhi?

There are several fertility centres in Delhi. Here’s what makes Mediworld Fertility a specific choice for couples dealing with recurrent pregnancy loss.

• Depth of experience. Fifteen years in reproductive medicine and over 1,500 recurrent pregnancy loss cases managed. This is not a condition we see occasionally. It’s a core part of what we do.
• Advanced diagnostics under one roof. Hormonal testing, genetic testing, hysteroscopy, uterine imaging, immunological workup, and semen analysis are all available at our centres. A complete evaluation doesn’t require multiple hospital visits.
• Evidence-based treatment protocols. We follow current guidelines from ASRM, RCOG, and published clinical data. Treatments are recommended based on what the evidence shows for your specific diagnosis, not on assumptions.
• IVF and genetic screening capability. With 2,000+ IVF and ICSI cycles completed and advanced cryopreservation labs, we have the infrastructure for complex chromosomal cases requiring PGT-A.
• Counselling as standard. We have conducted over 2,000 couple counselling sessions. Recurrent pregnancy loss has a significant emotional component, and treatment that ignores that isn’t complete treatment.
• 95% success rate in advanced IVF and fertility treatments, reflecting the quality of our clinical protocols and laboratory standards.
• Multiple centres across Delhi NCR. Our Safdarjung Enclave centre is our primary location, supported by satellite centres in Sukhdev Vihar, Faridabad, Ghaziabad, and Greater Noida. Wherever you are in the NCR, access to our specialists is practical.
• International patient support. Patients travelling from outside India for recurrent miscarriage evaluation and treatment receive dedicated support from our international team.

Start Your Recurrent Miscarriage Treatment at Mediworld Fertility

Repeated pregnancy loss deserves a proper answer, not another cycle of waiting and hoping.

Two things matter most here: recurrent miscarriage has an identifiable cause in the majority of cases, and treatments exist for every major cause category. The process starts with the right evaluation. That’s it.

At Mediworld Fertility in Delhi, our team has helped over 1,500 couples move from repeated loss to successful pregnancy. That experience, combined with our advanced diagnostic and treatment infrastructure, means we can give your case the attention and precision it deserves.

Book a consultation with our recurrent miscarriage specialists today. Call us, WhatsApp us, or fill out the contact form on our website. The first step is finding out what’s causing your losses. Everything else follows from there.

Frequently Asked Questions

1. What are the risk factors for recurrent miscarriage?

The main risk factors for recurrent miscarriage include advanced maternal age (risk rises sharply after 33 and again after 40), a prior history of miscarriages, thyroid disorders, PCOS, antiphospholipid antibodies, obesity, hypertension, uncontrolled diabetes, and tobacco use. Indian data from the NFHS-5 survey, published in 2024, confirmed that thyroid disorders, obesity, hypertension, and tobacco chewing are all significantly associated with pregnancy loss among Indian women. Male factor issues, including sperm DNA fragmentation, can also contribute and should be evaluated.

2. What are the types of recurrent miscarriage?

Recurrent miscarriage is classified in two ways. The first is by whether a successful pregnancy has occurred before: primary recurrent pregnancy loss means no live birth has ever happened, while secondary means losses follow at least one healthy pregnancy. The second classification is by the timing of loss: early recurrent miscarriage occurs before 10 weeks and is most commonly linked to chromosomal causes, while late recurrent miscarriage (between 10 and 20 weeks) is more often associated with structural uterine problems, APS, or cervical issues. Both types need full investigation, though the diagnostic focus shifts slightly depending on timing.

3. What complications can recurrent miscarriage cause?

Beyond the direct physical impact of each loss, recurrent miscarriage carries significant risks to mental health. Anxiety disorders, depression, and post-traumatic stress are well documented among couples with a history of repeated pregnancy loss. The fear of another miscarriage can affect the experience of any subsequent pregnancy, even when it is progressing normally. There are also practical fertility implications: repeated uterine interventions (such as D&C procedures after each loss) carry a small risk of intrauterine scarring. This is why evaluation and targeted treatment matter more than repeated cycles of loss without investigation.

4. How is recurrent miscarriage diagnosed and what tests are involved?

Diagnosis begins with a detailed review of reproductive and medical history, including the timing and circumstances of each loss. Testing then covers four areas. Genetic testing involves karyotyping of both partners. Uterine evaluation uses ultrasound, hysteroscopy, or HSG to check for structural problems inside the uterine cavity. Hormonal testing covers thyroid function, prolactin, progesterone, blood sugar, and ovarian reserve. Immunological testing checks for antiphospholipid antibodies, lupus anticoagulant, and anticardiolipin antibodies. Semen analysis and sperm DNA fragmentation testing evaluate the male partner’s contribution. TORCH infection screening is included where indicated. No single test is sufficient; the full panel is needed for an accurate diagnosis.

5. What are the treatment options for recurrent miscarriage in Delhi?

Treatment depends on the cause identified during evaluation. For antiphospholipid syndrome, low-dose aspirin plus heparin is the established first-line approach. For uterine structural problems like a septum or fibroids, hysteroscopic surgery corrects the cavity. For chromosomal causes, IVF with preimplantation genetic testing (PGT-A) allows transfer of only chromosomally normal embryos. Hormonal causes like thyroid dysfunction are treated with targeted medication. For unexplained recurrent pregnancy loss, supportive early pregnancy care and lifestyle changes improve outcomes meaningfully. At Mediworld Fertility in Delhi, treatment plans are built around what the investigation actually shows for each individual couple.

6. Can recurrent miscarriage be prevented or managed?

Some causes of recurrent miscarriage can be prevented or substantially reduced with the right intervention. Managing thyroid disorders, controlling blood sugar, treating APS with aspirin and heparin, and correcting uterine structural problems all reduce the risk of further loss. Lifestyle factors within a person’s control, including maintaining a healthy weight, stopping tobacco use, and managing blood pressure, also reduce risk. For couples with chromosomal causes, IVF with PGT-A manages rather than prevents the underlying cause by selecting unaffected embryos. For unexplained RPL, attending a specialist early pregnancy clinic with structured monitoring and support has been shown to significantly improve outcomes even without pharmacological treatment.

7. What is the prognosis after recurrent miscarriage treatment?

The prognosis is good for most couples who receive proper evaluation and appropriate treatment. Even without treatment, roughly 70% of couples who have had three consecutive miscarriages go on to carry a successful pregnancy. With treatment, outcomes improve further depending on the cause: couples with APS see live birth rates of 71% or more with aspirin plus heparin therapy; couples with a uterine septum see live birth rates around 75% after hysteroscopic resection; couples using IVF with PGT-A after chromosomal losses see substantially reduced miscarriage rates per transfer. At Mediworld Fertility, with over 1,500 recurrent pregnancy loss cases managed and a 95% success rate in advanced fertility treatments, the clinical experience backs up what the studies show.